Monitoring the use of amiodarone: Compliance with guidelines

Internal Medicine Journal

Volumn 36, Issue 5, 2006, Pages 289-293

  Burgess, C ^a   Blaikie, A ^a   Ingham, T ^a   Robinson, G ^b   Narasimhan, S ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Adherence; Amiodarone; Compliance; Guidelines; Liver; Thyroid

Indexed keywords

AMIODARONE; DIGOXIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; DRUG MONITORING; DRUG UTILIZATION; ELECTROCARDIOGRAM; EYE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROLOGIC DISEASE; NEW ZEALAND; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SINUS RHYTHM; SKIN DISEASE; TACHYCARDIA; THORAX RADIOGRAPHY; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; TIME SERIES ANALYSIS;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DRUG MONITORING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL AUDIT; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 33645736555     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01068.x     Document Type: Article

References (17)

1. Khan M. Oral class III antiarrythmics: what is new? Curr Opin Cardiol 2004 19 47 51.
2. Kochiadikis G Igoumenidis E Hamilos M Tzerakis G Klapsinos N Zacharis E et al. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation. Chest 2004 125 377 83.
3. Roy D Talajic M Dorian P Connolly S Eisenberg M Green M et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000 342 913 20.
4. Anon. Using amiodarone safely [editorial]. Drug Ther Bull 2003 41 9 12.
5. Harris L McKenna W Rowland E Krickler D. Side effects and possible contraindications of amiodarone use. Am Heart J 1983 106 916 23.
6. Podrid P. Amiodarone: re-evaluation of an old drug: a meta-analysis. Ann Intern Med 1995 122 689 700.
7. Vorperian V Havighurst T Miller S January C. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997 30 791 8.
8. Siddoway L. Amiodarone: guidelines for use and monitoring. Am Fam Physician 2003 68 2189 96.
9. Stelfox H Ahmed S Fiskio J Bates D. Monitoring amiodarone toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther 2004 75 110 22.
10. Goldschlager N Epstein A Naccarelli G Olshansky B Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Arch Intern Med 2000 160 1741 8.
11. British National Formulary. Amiodarone. BNF 47. Leck, Germany Clausen and Bosse, CPI Books.
12. Data Sheets. Aratac and Cordarone X. Available from: URL http://www.medsafe.govt.nz/profs/Datasheet/a/Aratactab.htm [cited 2004] and http://www.medsafe.govt.nz/profs/Datasheet/c/CordaroneXtabinj.htm [cited 2005]
13. Horowitz L. Detection of amiodarone pulmonary toxicity: to screen or not to screen, that is the question. J Am Coll Cardiol 1988 12 789 90.
14. Mason J. Prediction of amiodarone-induced pulmonary toxicity. Am J Med 1989 86 2 3.
15. Ott M Khoor A Leventhal J Paterick T Burger C. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 2003 123 646 51.
16. Ashrafian H Davey P. Is amiodarone an unrecognised cause of acute respiratory failure in ICU? Chest 2001 120 275 82.
17. Graham M Wright M Manley H. Effectiveness of an amiodarone protocol and management clinic in improving adherence to amiodarone monitoring guidelines. J Pharm Technol 2004 20 5 10.